About this trial
Neck pain frequently present comorbidities in peridiaphragmatic organs. The innervation of these organs include the phrenic nerve. It is known that peridiaphragmatic organs trigger referred pain in the neck area. As well, previous studies have shown that visceral disorders increase sensitization in somatic tissues. This study aims to analyze the ability of phrenic nerve infiltration to diminish sensitization and improve neck symptoms in the absence of neurological, traumatic or infectious pathology that justifies the pain, by means of a randomized controlled trial.
Eligibility criteria
Qualifiers
Over 18 and under 64 years old
Patients attending to the physician or physical therapist with a main complaint of neck pain
Presentation of any peridiaphragmatic visceral disorder.
That the subject agrees to participate in the project by signing the informed consent.
Disqualifiers
Illness of neurological, traumatic, oncological, infectious or rheumatic (fibromyalgia, ankylosing spondylitis...) origin.
Uncooperative subject.
Severe psychiatric illness.
Loss of Cognitive Ability.
Trial design
Treatments tested in this trial
- Bupivacaine
- Placebo (physiological saline serum infiltration)